Neoplastic Meningitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases
Conditions: HER2/Neu Positive; Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Leptomeninges Intervention: Biological: Chimeric Antigen Receptor T-Cell Therapy Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2018 Category: Research Source Type: clinical trials
HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases
Conditions: HER2/Neu Positive; Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Leptomeninges Intervention: Biological: Chimeric Antigen Receptor T-Cell Therapy Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2018 Category: Research Source Type: clinical trials
BATs in Patients With Breast Cancer and Leptomeningeal Metastases
Conditions: Breast Cancer Female; Leptomeningeal Metastases Intervention: Drug: HER2 BATs Sponsor: University of Virginia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2018 Category: Research Source Type: clinical trials